Aayush Wellness H1 FY27 Results and Auditor Update

Consolidated H1 FY27 Income reached Rs 70.62 crore, marking a 10.61% YoY increase.
Consolidated H1 FY27 Profit After Tax stood at Rs 2.50 crore, up 5.86% YoY.

Reader Takeaway: Consistent top-line growth driven by new product launches, though investors should monitor margin sustainability and operational efficiency.

What just happened

Aayush Wellness Ltd released its consolidated financial results for the half-year ended September 30, 2026. The board also confirmed the appointment of M/s. NKM & Associates as the new secretarial auditor for the fiscal year 2026-27, effective November 03, 2026.

Financial Performance

The company demonstrated steady growth in the first half of the fiscal year. Consolidated total income rose to Rs 70.62 crore, compared to Rs 63.85 crore in H1 FY26. On a quarterly basis, Q2 FY27 income was recorded at Rs 36.86 crore, an improvement over the Rs 33.76 crore reported in Q1 FY27. Profit After Tax for H1 FY27 saw a modest rise to Rs 2.50 crore from Rs 2.36 crore in the same period last year.

Product Expansion

Aayush Wellness continues to push into preventive wellness. Recent launches include Aayush Calcium Vitamin Tablets in October 2026, Lung Care Tablets in August 2026, and Dia Shield Tablets in May 2026. The firm is blending traditional health practices with modern nutrition to capture a larger market share in the preventive health segment.

What to track next

Shareholders should track whether these new product launches effectively scale and if the company can maintain or expand its margins in the upcoming quarters as competitive pressures in the wellness sector fluctuate.